Literature DB >> 21148281

Invasive disease caused by Haemophilus influenzae type a in Northern Ontario First Nations communities.

Len Kelly1, Raymond S W Tsang2, Alanna Morgan1, Frances B Jamieson3,4, Marina Ulanova1.   

Abstract

Seven epidemiologically unrelated cases of invasive Haemophilus influenzae type a (Hia) disease were identified in First Nations communities of Northwestern Ontario, Canada, in 2004-2008. In all cases, Hia was isolated from blood. The clinical presentation in most of the cases was moderately severe and all patients responded to antibiotic therapy. Laboratory analysis of Hia isolates from Northwestern Ontario indicated striking similarities in their phenotypic and genotypic characteristics. The findings are discussed in the context of current epidemiology of invasive Hia disease. Our data along with some published studies by others suggest an increased susceptibility to this infection among North American indigenous populations.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21148281     DOI: 10.1099/jmm.0.026914-0

Source DB:  PubMed          Journal:  J Med Microbiol        ISSN: 0022-2615            Impact factor:   2.472


  17 in total

1.  Vaccines shoot for more precise population targets.

Authors:  Alla Katsnelson
Journal:  Nat Med       Date:  2012-04-05       Impact factor: 53.440

2.  Emergence of non-serotype b encapsulated Haemophilus influenzae as a cause of pediatric meningitis in northwestern Ontario.

Authors:  Pouya Sadeghi-Aval; Raymond Sw Tsang; Frances B Jamieson; Marina Ulanova
Journal:  Can J Infect Dis Med Microbiol       Date:  2013       Impact factor: 2.471

3.  The emerging Haemophilus influenzae serotype a infection and a potential vaccine: Implementation science in action.

Authors:  L Barreto; A D Cox; M Ulanova; M G Bruce; Rsw Tsang
Journal:  Can Commun Dis Rep       Date:  2017-05-04

4.  Developing a vaccine for Haemophilus influenzae serotype a: Proceedings of a workshop.

Authors:  A D Cox; L Barreto; M Ulanova; M G Bruce; Rsw Tsang
Journal:  Can Commun Dis Rep       Date:  2017-05-04

5.  Naturally acquired antibodies against Haemophilus influenzae type a in Aboriginal adults, Canada.

Authors:  Eli B Nix; Kylie Williams; Andrew D Cox; Frank St Michael; Sandra Romero-Steiner; Daniel S Schmidt; William G McCready; Marina Ulanova
Journal:  Emerg Infect Dis       Date:  2015-02       Impact factor: 6.883

6.  Development and validation of an Haemophilus influenzae supragenome hybridization (SGH) array for transcriptomic analyses.

Authors:  Benjamin A Janto; N Luisa Hiller; Rory A Eutsey; Margaret E Dahlgren; Joshua P Earl; Evan Powell; Azad Ahmed; Fen Z Hu; Garth D Ehrlich
Journal:  PLoS One       Date:  2014-10-07       Impact factor: 3.240

7.  Indigenous populations health protection: a Canadian perspective.

Authors:  Katya L Richardson; Michelle S Driedger; Nick J Pizzi; Jianhong Wu; Seyed M Moghadas
Journal:  BMC Public Health       Date:  2012-12-20       Impact factor: 3.295

8.  Haemophilus influenzae serotype a invasive disease, Alaska, USA, 1983-2011.

Authors:  Michael G Bruce; Tammy Zulz; Carolynn DeByle; Ros Singleton; Debby Hurlburt; Dana Bruden; Karen Rudolph; Thomas Hennessy; Joseph Klejka; Jay D Wenger
Journal:  Emerg Infect Dis       Date:  2013-06       Impact factor: 6.883

9.  No evidence of increasing Haemophilus influenzae non-b infection in Australian Aboriginal children.

Authors:  Robert I Menzies; Peter Markey; Rowena Boyd; Ann P Koehler; Peter B McIntyre
Journal:  Int J Circumpolar Health       Date:  2013-08-05       Impact factor: 1.228

10.  Design and validation of a supragenome array for determination of the genomic content of Haemophilus influenzae isolates.

Authors:  Rory A Eutsey; N Luisa Hiller; Joshua P Earl; Benjamin A Janto; Margaret E Dahlgren; Azad Ahmed; Evan Powell; Matthew P Schultz; Janet R Gilsdorf; Lixin Zhang; Arnold Smith; Timothy F Murphy; Sanjay Sethi; Kai Shen; J Christopher Post; Fen Z Hu; Garth D Ehrlich
Journal:  BMC Genomics       Date:  2013-07-17       Impact factor: 3.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.